参考文献/References:
[1] 邱英鹏,赵翔,肖月,等. 高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(5):1-3.
[2] 何书芬,蒋璐伊,徐源,等. 基于内容分析法的我国医用耗材政策热点可视化分析[J].中国医院管理,2019,39(9):30-32.
[3] 孙黄颖,孙巧,李弯,等.建立医用耗材综合价值评估指标体系初探[J].中国医疗保险,2021(11):34-38.
[4] Blüher M,Saunders S,Mittard V,et al.Critical review of European Health-Economic Guidelines for the health technology assessment of medical devices[J].Frontiers in Medicine,2019(6):278.
[5] Oriana,Ciani,Britni,et al.Health technology assessment of medical devices:a survey of non-European union agencies[J].International Journal of Technology Assessment in Health Care,2015,31(3):154-165.
[6] International society for pharmacoeconomics and outcomes research.Pharmacoeconomic Guidelines Around The World[EB/OL]. [2022-01-10].https://tools.ispor.org/peguidelines.
[7] The international network of agencies for health technology assessment.Inahta Members List[EB/OL].[2022-01-10].https://www.inahta.org/members/members_list.
[8] National institute for health and care excellence.Medical Technologies Evaluation Programme Methods Guide[EB/OL].[2022-01-10].https://www.nice.org.uk/process/pmg33/chapter/introduction.
[9] The dental and pharmaceutical benefits agency.Economic Evaluation of Medical Devices[EB/OL].[2022-01-10].www.tlv.se.
[10] Zorginstituut nederland. Guideline for Economic Evaluations in Healthcare[EB/OL].[2022-01-10].https://tools.ispor.org/PEguidelines/countrydet.asp?c=22&t=1.
[11] Pharmaceutical management agency.Prescription for Pharmacoeconomic Analysis Methods for cost-utility analysis[EB/OL].[2022-01-10].https://pharmac.govt.nz/medicine-funding-and-supply/the-funding-process/policies-manuals-and-processes/economic-analysis/prescription-for-pharmacoeconomic-analysis-methods-for-cost-utility-analysis.
[12] Health information and quality authority.Guidelines for the Economic Evaluation of Health Technologies in Ireland[EB/OL].[2022-01-10].https://www.hiqa.ie/sites/default/files/2019-07/HT
A-Economic-Guidelines-2019.pdf.
[13] The Canadian agency for drugs and technologies in health.Guidelines for the Economic Evaluation of Health Technologies:Canada[EB/OL].[2022-01-10].https://cadth.ca/sites/default/files/pdf/guidelines_for_the_economic_evaluation_of_health_technolo
gies_canada_4th_ed.pdf.
[14] National institute of pharmacy and nutrition.Professional Healthcare Guideline onthe Methodologyof Health Technology Assessment[EB/OL].[2022-01-10].https://tools.ispor.org/PEguidelines/source/HTA_Guideline_HUN_eng.pdf.
[15] Academy of Managed Care Pharmacy.A format for submission of clinical and economic evidence in support of formulary consideration[EB/OL].[2022-01-10].https://www.amcp.org/sites/default/files/2019-03/AMCP-Format-V4.pdf.
[16] Study team for“Establishing Evaluation Methods, Data Standardization,and Assessment Systems Toward the Application of Economic Evaluation of Healthcare Technologies to Governmental Policies”.Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council[EB/OL].[2022-01-10].https://tools.ispor.org/PEguidelines/source/Japanese_PE_Gui
deline.pdf.
[17] The belgian health care knowledge centre. Belgian Guidelinesfor Econemic Evaluationsand Budget Impact Analyses: Second Edition[EB/OL].[2022-01-10].https://kce.fgov.be/sites/default/files/atoms/files/KCE_183_economic_evaluations_second_edition_Re
port_upda-te.pdf.
[18] Daccache C,Rizk R, Dahham J,et al.Economic evaluation guidelines in low-and middle-income countries:a systematic review[J].Int J Technol Assess Health Care,2021,38(1):e1.
[19] World Health Organization.Health technology assessment of medical devices[EB/OL].[2022-01-10].https://www.who.int/publications-detail-redirect/9789241501361.
相似文献/References:
[1]安 珂,李晓琪,杨 洁.现行医疗服务价格的合理性浅析[J].卫生经济研究,2016,(12):37.
[2]陈宏志.医院科室医用耗材二级库自动补货模式探讨[J].卫生经济研究,2017,(11):37.
[3]杜学鹏,零春晴,陈文大.公立医院耗占比管控困难的原因及对策研究[J].卫生经济研究,2020,(09):54.
DU Xue-peng,LING Chun-qing,CHEN Wen-da.Study on the Causes and Countermeasures of Difficulty in the Management and Control of Medical Consumables Proportion in Public Hospitals[J].Journal Press of Health Economics Research,2020,(11):54.
[4]王雅洁,徐 伟,陈明艳.江苏省医用耗材带量采购的做法及实施情况分析[J].卫生经济研究,2020,(12):21.
WANG Ya-jie,XU Wei,CHEN Ming-yan.Analysis on the Practice and Implementation of Volume-based Procurement of Medical Consumable Materials in Jiangsu Province[J].Journal Press of Health Economics Research,2020,(11):21.
[5]姚奕婷,陈元栋,张远妮,等.广东省公立医院取消药品、医用耗材加成的效果研究[J].卫生经济研究,2020,(12):32.
YAO YI-ting,CHEN Yuan-dong,ZHANG Yuan-ni,et al.Study on the Effect of Canceling the Addition of Drugs and Medical Consumables in Public Hospitals in Guangdong Province[J].Journal Press of Health Economics Research,2020,(11):32.
[6]范志琴,邱晶青,吴 赛,等.肿瘤患者住院期间PICC直接耗材成本的影响因素分析[J].卫生经济研究,2020,(12):56.
FAN Zhi-qin,QIU Jing-qing,WU Sai,et al.Analysis on Influences Factors of PICC Direct Consumables Cost in Tumor Patients during Hospitalization[J].Journal Press of Health Economics Research,2020,(11):56.
[7]程寿锦,徐立德.SPD系统在医院耗材使用管控中的实践应用[J].卫生经济研究,2021,38(9):68.
CHENG Shou-jin,XU Li-de.Practical Application of SPD System in the Management and Control of Hospital Consumables[J].Journal Press of Health Economics Research,2021,38(11):68.
[8]谭清立,周芷婷.医用耗材带量采购的医保支付政策研究[J].卫生经济研究,2021,38(11):6.
TAN Qing-li,ZHOU Zhi-ting.Research on Medical Insurance Payment Policy for Centralized Medical Consumables Volume-based Purchasing[J].Journal Press of Health Economics Research,2021,38(11):6.
[9]黄晓青,王煜昊,王丽娜,等.医用耗材集采背景下按病种分值付费优化方案研究 ——以冠状动脉支架为例[J].卫生经济研究,2022,39(10):16.
HUANG Xiaoqing,WANG Yuhao,WANG Lina,et al.Research on Policy Optimization of Diagnosis-Intervention Packet Based the Volume-Based Procurement of Medical Comsumables ——Taking Coronary Stents as an Example[J].Journal Press of Health Economics Research,2022,39(11):16.
[10]孔维政,贾宇飞,姜 来,等.多层次医疗保障体系下高值医疗器械保障机制的探索[J].卫生经济研究,2022,39(10):20.
KONG Weizheng,JIA Yufei,JIANG Lai,et al.Exploration of High-Value Medical Equipment Compensation in the Context of Multi-Level Medical System[J].Journal Press of Health Economics Research,2022,39(11):20.